Go Pro

Cigna Group (NYSE:CI) Receives Average Rating of "Moderate Buy" from Analysts

Cigna Group logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Analysts maintain a “Moderate Buy” consensus on Cigna, with 15 buy ratings and seven holds among 22 research firms. The average 12-month price target is $339.45, above the stock’s reported opening price of $278.13.
  • Cigna’s latest quarterly results exceeded expectations, with adjusted EPS of $7.78 versus the $7.60 consensus estimate, while revenue rose 6.7% year over year to $70.04 billion. The company reaffirmed fiscal 2026 EPS guidance of approximately $30.45.
  • The company declared a quarterly dividend of $1.56 per share, equivalent to $6.24 annually and a 2.2% yield. Recent insider transactions included stock sales by two executives, while institutional investors own nearly 87% of outstanding shares.
  • Five stocks to consider instead of Cigna Group.

Shares of Cigna Group (NYSE:CI - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the twenty-two research firms that are presently covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and fifteen have issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $339.45.

A number of research firms have issued reports on CI. Sanford C. Bernstein lifted their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the stock an "outperform" rating in a report on Thursday, July 9th. Jefferies Financial Group lowered shares of Cigna Group from a "buy" rating to a "hold" rating and dropped their price target for the company from $336.00 to $307.00 in a research report on Tuesday, August 4th. Royal Bank Of Canada boosted their price target on shares of Cigna Group from $333.00 to $337.00 and gave the stock an "outperform" rating in a report on Friday, May 1st. Barclays increased their price objective on shares of Cigna Group from $304.00 to $310.00 and gave the company an "equal weight" rating in a research note on Friday, July 31st. Finally, Wall Street Zen cut shares of Cigna Group from a "buy" rating to a "hold" rating in a research report on Saturday, August 1st.

Check Out Our Latest Research Report on CI

Cigna Group Stock Down 1.5%

CI stock opened at $278.13 on Tuesday. The firm has a market capitalization of $73.49 billion, a PE ratio of 11.51, a P/E/G ratio of 0.97 and a beta of 0.29. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a twelve month low of $239.51 and a twelve month high of $315.47. The stock's 50 day moving average is $286.08 and its 200-day moving average is $281.31.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. The business had revenue of $70.04 billion during the quarter, compared to the consensus estimate of $70.14 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%.Cigna Group's revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $7.20 earnings per share. Cigna Group has set its FY 2026 guidance at 30.450- EPS. Sell-side analysts expect that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend is Tuesday, September 8th. Cigna Group's dividend payout ratio (DPR) is presently 25.82%.

Insiders Place Their Bets

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the company's stock in a transaction on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer owned 2,368 shares in the company, valued at $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Nicole S. Jones sold 19,436 shares of the firm's stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider directly owned 27,256 shares of the company's stock, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company's stock.

Hedge Funds Weigh In On Cigna Group

Several institutional investors have recently added to or reduced their stakes in CI. Wilkerson Advisory Group LLC purchased a new position in shares of Cigna Group in the fourth quarter worth about $25,000. Johnson Financial Group Inc. purchased a new stake in shares of Cigna Group during the 2nd quarter valued at approximately $29,000. Kemnay Advisory Services Inc. bought a new position in Cigna Group in the 4th quarter worth approximately $29,000. Prosperity Bancshares Inc bought a new position in Cigna Group in the 4th quarter worth approximately $29,000. Finally, Cedar Mountain Advisors LLC grew its stake in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider's stock valued at $29,000 after buying an additional 68 shares in the last quarter. Institutional investors own 86.99% of the company's stock.

About Cigna Group

(Get Free Report)

Cigna Group NYSE: CI is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Analyst Recommendations for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines